HomeProductsBioactive CompoundsNeuronal SignalingP2X ReceptorGefapixant
Chemical structure of CAS 1015787-98-0

Gefapixant

CAS No.1015787-98-0
MDL No.MFCD24539325
MFC14H19N5O4S
MW353.40
InChI KeyHLWURFKMDLAKOD-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1015787-98-0
Product NameGefapixant

Biological Targets

P2RX3

Associated Conditions

asthma·osteoarthritis, knee·Cough·idiopathic pulmonary fibrosis·Renal insufficiency·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Gefapixant: First Approval.

Drugs • Vol. 82, Issue 6 • 2022
PMID: 35347635DOI: 10.1007/s40265-022-01700-8

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.

British journal of pharmacology • Vol. 176, Issue 13 • 2019
PMID: 30927255PMC: PMC6555852DOI: 10.1111/bph.14677

Medicinal chemistry of adenosine, P2Y and P2X receptors.

Neuropharmacology • Vol. 104 • 2016
PMID: 26686393PMC: PMC4871727DOI: 10.1016/j.neuropharm.2015.12.001

Documentation

Similar Products